Terpenoid ID | TKC016420 | |
Chirality | TKC016414 | |
Cell line | 0 | |
Protein target | 7 | |
DiseaseNCIT | 0 | |
ORDO | 0 | |
ICD | 14 |
ID | Cell Line | Synonyms | Value | Unit | Type | NCIt | ORDO |
---|---|---|---|---|---|---|---|
TKC016420 | H4 | H-4 | 32959.0 | nM | EC50 | C60781 | Orphanet_94 |
TKC016420 | HL-60 | HL 60; HL.60 HL60; Human Leukemia-60 | 6300.0 | nM | GI50 | C9154 | Orphanet_519 |
ID | Uniport | Pref_name | Gene name | value | unit | type |
---|---|---|---|---|---|---|
TKC016420 | Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | TDP1 | 3663 | nM | Potency |
TKC016420 | Q16236 | Nuclear factor erythroid 2-related factor 2 | NFE2L2 | 35481 | nM | Potency |
TKC016420 | Q99700 | Ataxin-2 | ATXN2 | 31623 | nM | Potency |
TKC016420 | O75496 | Geminin | GMNN | 7308 | nM | Potency |
TKC016420 | P01215 | Glycoprotein hormones alpha chain | CGA | 28184 | nM | Potency |
TKC016420 | P83916 | Chromobox protein homolog 1 | CBX1 | 56234 | nM | Potency |
TKC016420 | Q96QE3 | ATPase family AAA domain-containing protein 5 | ATAD5 | 16354 | nM | Potency |
Uniport ID | Uniport Name | ICD-11 |
---|---|---|
Q16236 | NF2L2_HUMAN | Ataxic disorder [ICD-11: 8A03] |
Q16236 | NF2L2_HUMAN | Breast cancer [ICD-11: 2C60-2C6Y] |
Q16236 | NF2L2_HUMAN | Glaucoma [ICD-11: 9C61] |
Q16236 | NF2L2_HUMAN | Lung cancer [ICD-11: 2C25] |
Q16236 | NF2L2_HUMAN | Macular degeneration [ICD-11: 9B75] |
Q16236 | NF2L2_HUMAN | Melanoma [ICD-11: 2C30] |
Q16236 | NF2L2_HUMAN | Mental/behavioural/neurodevelopmental disorder [ICD-11: 6E20-6E8Z] |
Q16236 | NF2L2_HUMAN | Pulmonary hypertension [ICD-11: BB01] |
Q16236 | NF2L2_HUMAN | Subarachnoid haemorrhage [ICD-11: 8B01] |
Q16236 | NF2L2_HUMAN | Urinary system clinical sympton [ICD-11: MF8Y] |
Q16236 | NF2L2_HUMAN | Non-alcoholic fatty liver disease [ICD-11: DB92] |
Q16236 | NF2L2_HUMAN | Alpha-1-antitrypsin deficiency [ICD-11: 5C5A] |
Q16236 | NF2L2_HUMAN | Motor neuron disease [ICD-11: 8B60] |
Q16236 | NF2L2_HUMAN | Multiple sclerosis [ICD-11: 8A40] |